drug · small molecule
AV-1
Phase 2updated 3mo agoby AbViro LLC🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
Glutamate [NMDA] receptor
all catalysts(0)
nothing on the calendar yet
Trials studying AV-1
- phase2A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection
- phase1Study of AV-1959D, an Amyloid Beta Vaccine
- phase1Phase I Clinical Study of AV-1959R: Abeta-targeting Anti-Alzheimer's Vaccine
- phase3PET Tau - Neurodegenerative Disease Imaging
- phase3Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)
- phase3A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)
- phase118F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
- N/AImaging Tau Deposition in the Brain of Elderly Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that